In terms of clinical management, the inclusion of testing greatly enables the confirmation of dengue virus (DENV) infection through the detection of dengue‐specific antigens (e.g., NS1) or antibodies (e.g., IgM). This evidence concerns the gene CD40LG and dengue disease.